Search clinical trials for: Estrofem

Total 2065 results

Sanofi
European Organisation for Research and Treatment of Cancer - EORTC; Alliance... and other collaborators

Terminated

Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity (AMEERA-6)

Breast Cancer

Chile, China
Veru Inc.

Completed

Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer

Prostate Cancer Metastatic

United States
University of Illinois at Chicago

Withdrawn

Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and Hypoandrogenism

Hypogonadism | Non Obstructive Azoospermia

Spain
Bayer

Completed

3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women

Osteopenia
Pfizer

Completed

Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women

Endometrial Hyperplasia | Osteoporosis

United States
University Hospital Birmingham

Unknown

Tamoxifen in Treating Women With Breast Cancer

Breast Cancer

United Kingdom
National Medical Research Council (NMRC), Singapore

Completed

Tamoxifen in Treating Patients With Primary Liver Cancer

Liver Cancer

New Zealand, Hong Kong, Indonesia, Malaysia, Pakistan, Singapore
Fundació Privada Eugin

Completed

Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in IVF Cycles (CLOFA)

Female Infertility

Spain
Milton S. Hershey Medical Center
Mayo Clinic

Completed

Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women

Infertility

United States
Massachusetts General Hospital

Active, not recruiting

Comparative Antiresorptive Efficacy Discontinuation of Denosumab

Osteoporosis | Osteoporosis, Postmenopausal

United States
Ain Shams Maternity Hospital

Unknown

Clomiphene Citrate Stair-Step Protocol

Polycystic Ovary

Egypt
Shionogi
QuatRx Pharmaceuticals

Completed

Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus

Atrophy | Vaginal Diseases
Stanley Medical Research Institute

Completed

Tamoxifen in Treatment of Acute Mania

Bipolar Disorder

Turkey
European Institute of Oncology

Completed

Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer

Breast Cancer

Italy
University Magna Graecia

Withdrawn

Clomiphene Citrate in Infertile PCOS Patients

Polycystic Ovary Syndrome | Infertility

Italy
Federal University of São Paulo

Completed

Clomiphene in Males With Prolactinomas and Persistent Hypogonadism

Hypogonadotropic Hypogonadism | Prolactinoma

Brazil
University of Parma

Unknown

Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis

Retroperitoneal Fibrosis

Italy
Dr. Reddy's Laboratories SAS

Recruiting

Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-

Breast Neoplasm Female

Colombia
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaborators

Completed

Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

Breast Cancer

United States
Assaf-Harofeh Medical Center

Recruiting

Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders

Ovarian Hyperstimulation Syndrome | Miscarriage | Pregnancy Early

Israel
AstraZeneca

Completed

Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.

Endometrial Carcinoma

Germany
University of Utah

Recruiting

Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial

Rotator Cuff Tears

United States
James Dowling
Canadian Institutes of Health Research (CIHR); Cures Within Reach; The Joshua... and other collaborators

Recruiting

Tamoxifen Therapy for Myotubular Myopathy (TAM4MTM)

X Linked Myotubular Myopathy

United Kingdom, Canada, United States
Ain Shams Maternity Hospital

Recruiting

Parameters Declaring PCO Infertile Patients Either Sensitive or Resistant to Different Doses of Clomiphene Citrate.

PCO | Clomiphene Citrate | Induction of Ovulation

Egypt
Chinese Anti-Cancer Association
Zhejiang Cancer Hospital; Fudan University; Cancer Institute and Hospital, Chinese... and other collaborators

Recruiting

Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

Breast Cancer Female

China
Eli Lilly and Company

Active, not recruiting

A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer (Next MONARCH 1)

Metastatic Breast Cancer

Spain, Taiwan, United States, Italy, Czechia, Germany, Belgium, Turkey, Brazil, Russian Federation, Argentina, Austria, France, Mexico
Queen Mary University of London

Active, not recruiting

Tamoxifen for the Prevention of Breast Cancer in High-Risk Women (IBIS-1)

Breast Cancer

United Kingdom
Organon and Co

Completed

A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)

Osteoporosis, Postmenopausal
The Methodist Hospital Research Institute
Millennium Pharmaceuticals, Inc.

Completed

TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer (ANETT)

Estrogen Receptor Positive Breast Cancer

United States
Phoenix VA Health Care System

Completed

Clomid in Men With Low Testosterone With and Without Prior Treatment

Hypogonadism, Male

United States
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States, Canada
Taipei Medical University Shuang Ho Hospital

Completed

Tamoxifen Treatment in Patients With Motor Neuron Disease

Amyotrophic Lateral Sclerosis | ALS Functional Ration Scale | TAR-DNA-binding Protein-43 | Tamoxifen | mTOR

Taiwan
Wake Forest University
National Institute on Aging (NIA)

Completed

Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR)

Aging | Cognition

United States, Canada
University of Kansas Medical Center
National Cancer Institute (NCI)

Completed

Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

Breast Cancer

United States
Al Hayat National Hospital
Menoufia University

Unknown

Effect of Local Endometrial Injury on Pregnancy Outcomes During Ovulation Induction Cycles

Asymptomatic Diseases

Egypt
Nazem Atassi
State University of New York - Upstate Medical University; ALS Therapy Alliance

Completed

Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS) (SDALS-001)

Amyotrophic Lateral Sclerosis

United States
Children's Cancer and Leukaemia Group

Unknown

Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma

Brain and Central Nervous System Tumors

United Kingdom, Ireland
Novartis

Completed

Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density

Osteoporosis

United States
University of Oxford

Unknown

Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer

Breast Cancer

United Kingdom
Eli Lilly and Company

Completed

Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

Osteoporosis, Postmenopausal

United States
AstraZeneca

Completed

A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer | Locally Advanced or

Korea, Republic of
Fudan University

Unknown

The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast Cancer

Breast Neoplasms
AEterna Zentaris

Completed

Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

Non Small Cell Lung Cancer | Metastatic Breast Cancer | Solid Tumors | Sarcomas
Repros Therapeutics Inc.

Completed

Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism

Effect of Treatment on Bone Mineral Density

United States
University of Wisconsin, Madison

Completed

Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?

Osteoporosis

United States
Repros Therapeutics Inc.

Completed

Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

Breast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2)
Andrea DeCensi
European Institute of Oncology; Associazione Italiana per la Ricerca sul Cancro

Active, not recruiting

Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up (TAM-01)

Breast Neoplasms | Carcinoma, Intraductal, Noninfiltrating | Recurrence, Local Neoplasm | Atypical Hyperplasia

Italy
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology; NCIC Clinical Trials Group; Cancer...

Completed

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

Breast Cancer

United States, Canada
Oregon Health and Science University
Merck Women's Health Investigator Initiated Studies Program

Completed

Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users (Tamoxifen/BTB)

Bleeding | Breakthrough Bleeding | Implants

United States

Search clinical trials for: Estrofem

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations